News from anthera pharmaceuticals

( NASDAQ-NMS:ALKS,NASDAQ-NMS:AMLN)

Jul 14, 2014, 16:42 ET

Anthera Pharmaceuticals Announces Acquisition of Sollpura® (liprotamase) for Exocrine Pancreatic Insufficiency From Eli Lilly and Company

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) today announced that it has acquired Sollpura (liprotamase), a novel investigational Pancreatic Enzyme...

Jun 23, 2014, 17:00 ET

Anthera Pharmaceuticals Appoints Brian R. Mueller to Board of Directors

 Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), a biopharmaceutical company focused on developing and commercializing products to treat...

Jun 13, 2014, 15:30 ET

Anthera Pharmaceuticals Appoints Dr. Philip Sager to Board of Directors

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...

May 13, 2014, 08:30 ET

Anthera Pharmaceuticals Reports 2014 First Quarter Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and operational update for the first quarter ended March 31, 2014....

Mar 31, 2014, 16:30 ET

Anthera Pharmaceuticals Announces Personnel Changes

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...

Mar 12, 2014, 18:01 ET

Anthera Pharmaceuticals Reports 2013 Fourth Quarter And Fiscal Year Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and operational update for the fourth quarter and year ended...

Jan 30, 2014, 16:42 ET

Anthera Pharmaceuticals to Present at Leerink Swann, Cowen & Co., and BIO CEO Healthcare Conferences

 Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), a biopharmaceutical company focused on developing and commercializing products to treat...

Nov 27, 2013, 17:00 ET

Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...

Oct 29, 2013, 16:30 ET

Anthera Pharmaceuticals Reports 2013 Third Quarter Financial Results, Clinical and Regulatory Update

 Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results, clinical and regulatory update for the quarter ended...

Sep 25, 2013, 08:30 ET

Anthera Pharmaceuticals Announces Emerging Data from Phase 2 Open-Label Extension Study to be Presented at the ACR/ARHP 2013 Annual Scientific Meeting

Anthera Pharmaceuticals (NASDAQ: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...

Jul 30, 2013, 17:14 ET

Anthera Pharmaceuticals Reports 2013 Second Quarter Financial Results

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended June 30, 2013....

Jul 12, 2013, 17:00 ET

Anthera Pharmaceuticals Announces 1-for-8 Reverse Split of Stock

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) announced today that it has filed a Certificate of Amendment to its Amended and Restated Certificate...

Jun 24, 2013, 08:30 ET

Anthera Announces Initiation of BRIGHT-SC Phase 2 Clinical Study in IgA Nephropathy with Blisibimod

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with autoimmune...

Jun 21, 2013, 16:45 ET

Anthera Pharmaceuticals Announces Receipt of Nasdaq Notice

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) (the "Company"), a biopharmaceutical company focused on developing and commercializing products...

Jun 12, 2013, 16:30 ET

Anthera Pharmaceuticals Announces Personnel Changes

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced the appointment of May Liu as its Senior Vice President, Finance and...

May 31, 2013, 15:00 ET

Anthera Pharmaceuticals to Present at Annual Jefferies Healthcare Conference

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...

May 13, 2013, 17:23 ET

Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results

 Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended March 31st,...

May 07, 2013, 16:30 ET

Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat...

May 03, 2013, 14:06 ET

Anthera Announces First Quarter 2013 Financial Report and Conference Call

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune...

Apr 05, 2013, 17:45 ET

Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Analysts Review